$SLS Income Statement | Understand Stock

$SLS

$12.12 +$0.78 (6.88%) Live

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Licensing revenue
Operating expenses:
Cost of licensing revenue
Research and development
General and administrative
In-process research and development impairment charge
Acquired in-process research and development
Total operating expenses

Loss from operations
Non-operating income:
Change in fair value of warrant liability
Change in fair value of contingent consideration
Interest income
Total non-operating income
Loss before income taxes
Income tax benefit
Net loss
Deemed dividend arising from warrant modifications
Net loss attributable to common stockholders, basic
Net loss attributable to common stockholders, diluted
Per share information:
Net loss per common share, basic (in dollars per share)
Net loss per common share, diluted (in dollars per share)
Weighted-average common shares outstanding, basic (in shares)
Weighted-average common shares outstanding, diluted (in shares)

Comments